Biogen (BIIB) Debt to Equity (2016 - 2025)
Biogen has reported Debt to Equity over the past 16 years, most recently at $0.34 for Q4 2025.
- For Q4 2025, Debt to Equity fell 8.57% year-over-year to $0.34; the TTM value through Dec 2025 reached $0.34, down 8.57%, while the annual FY2025 figure was $0.34, 8.57% down from the prior year.
- Debt to Equity for Q4 2025 was $0.34 at Biogen, up from $0.01 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.47 in Q4 2022 and troughed at $0.01 in Q2 2025.
- A 5-year average of $0.29 and a median of $0.36 in 2025 define the central range for Debt to Equity.
- Biggest five-year swings in Debt to Equity: skyrocketed 414.62% in 2022 and later decreased 19.66% in 2024.
- Year by year, Debt to Equity stood at $0.09 in 2021, then skyrocketed by 414.62% to $0.47 in 2022, then fell by 0.07% to $0.47 in 2023, then decreased by 19.66% to $0.38 in 2024, then dropped by 8.57% to $0.34 in 2025.
- Business Quant data shows Debt to Equity for BIIB at $0.34 in Q4 2025, $0.01 in Q2 2025, and $0.38 in Q4 2024.